
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
Reviews children's books on birthdays, anniversaries, growing older, and the passing of time in keeping with the 2004 anniversary theme






